About Divi's Laboratories Limited
Divi's Laboratories Limited (DIVISLAB) has been publicly traded since 2003, making it a 23-year-old public company. It operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. The company is headquartered in Hyderabad, India and employs approximately 10,542 people. With a market capitalization of $1.6 trillion, DIVISLAB is one of the largest publicly traded companies.
Key Statistics
- Current Price
- ₹6,071.00
- Market Cap
- ₹1.61T
- 52-Week High
- ₹7,071.50
- 52-Week Low
- ₹4,955.00
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
₹1,000 Invested
Monthly Returns Heatmap
Annual Returns
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -5.03% | ₹6,392.50 | ₹6,071.00 |
| 2025 | +5.29% | ₹6,071.16 | ₹6,392.50 |
| 2024 | +57.18% | ₹3,862.50 | ₹6,071.16 |
| 2023 | +15.30% | ₹3,349.95 | ₹3,862.50 |
| 2022 | -26.48% | ₹4,556.63 | ₹3,349.95 |
| 2021 | +22.27% | ₹3,726.79 | ₹4,556.63 |
| 2020 | +109.70% | ₹1,777.23 | ₹3,726.79 |
| 2019 | +25.81% | ₹1,412.59 | ₹1,777.23 |
| 2018 | +36.03% | ₹1,038.41 | ₹1,412.59 |
| 2017 | +41.78% | ₹732.41 | ₹1,038.41 |
| 2016 | -31.44% | ₹1,068.21 | ₹732.41 |
| 2015 | +35.39% | ₹789.00 | ₹1,068.21 |
| 2014 | +43.01% | ₹551.71 | ₹789.00 |
| 2013 | +12.33% | ₹491.16 | ₹551.71 |
| 2012 | +43.90% | ₹341.32 | ₹491.16 |
| 2011 | +21.62% | ₹280.65 | ₹341.32 |
| 2010 | -3.69% | ₹291.39 | ₹280.65 |
| 2009 | +1.89% | ₹285.97 | ₹291.39 |
| 2008 | -28.63% | ₹400.68 | ₹285.97 |
| 2007 | +207.99% | ₹130.09 | ₹400.68 |
| 2006 | +101.70% | ₹64.50 | ₹130.09 |
| 2005 | +12.65% | ₹57.26 | ₹64.50 |
| 2004 | -12.09% | ₹65.13 | ₹57.26 |
Valuation
DIVISLAB currently trades at a trailing P/E ratio of 64.9, which is considered high relative to the broader market. The forward P/E of 51.9 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 10.5. The price-to-sales ratio is 15.6.
Dividends
Divi's Laboratories Limited pays a dividend to shareholders with a current yield of 0.49%. This translates to $30.00 per share annually. The payout ratio of 32% indicates sustainable dividend coverage.
Risk & Volatility
DIVISLAB has a beta of 0.12, indicating it is less volatile than the overall market. The stock's 52-week range is $4955.00 to $7071.50, and it currently trades in the upper half of its 52-week range.
Analyst Ratings
Based on 30 analyst opinions, DIVISLAB has a consensus "hold" rating. The average price target of $6875.33 suggests 13.2% upside from current levels.
Frequently Asked Questions
What does Divi's Laboratories Limited do? ▼
Divi's Laboratories Limited is a Drug Manufacturers - Specialty & Generic company operating in the Healthcare sector. The company is headquartered in Hyderabad, India.
What sector is DIVISLAB in? ▼
DIVISLAB operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
When did DIVISLAB go public? ▼
Divi's Laboratories Limited went public in 2003, making it a 23-year-old public company as of 2026.
How much would $1,000 invested in DIVISLAB 5 years ago be worth today? ▼
A $1,000 investment in DIVISLAB five years ago would be worth approximately $1,681 today, representing a 68.1% return.
Does DIVISLAB pay dividends? ▼
Yes, Divi's Laboratories Limited pays a dividend with a current yield of 0.49%, which is $30.0 per share annually.
What is DIVISLAB's market cap? ▼
Divi's Laboratories Limited has a market capitalization of $1.6 trillion, classifying it as a mega-cap company.
What is DIVISLAB's P/E ratio? ▼
DIVISLAB has a trailing P/E ratio of 64.9 and a forward P/E of 51.9, which measures how much investors are paying per dollar of earnings.
Is DIVISLAB a buy, hold, or sell? ▼
Based on 30 opinions, DIVISLAB has a consensus "hold" rating. The average price target is $6875.33.
Last updated: 3/14/2026